---
title: "分析師發現股價低於 100 美元且有可靠業績記錄的分紅股票"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/286659466.md"
description: "分析師強調了低於 100 美元的股息股票，其中麥考密克公司以 4.1% 的收益率和 40 年的增長領先。AGNC Investment、Blue Owl Capital 和 Enterprise Products Partners 的收益率從 5.9% 到超過 13%，均由現金流支撐。當前市場條件，包括較低的指數收益率和潛在的美聯儲寬鬆，正在推動投資者向可靠的股息股票傾斜"
datetime: "2026-05-17T03:19:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286659466.md)
  - [en](https://longbridge.com/en/news/286659466.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286659466.md)
---

# 分析師發現股價低於 100 美元且有可靠業績記錄的分紅股票

Dividend aristocrats focus: McCormick & Company leads with a 4.1% yield and four decades of annual dividend hikes. Yield supported by cash: AGNC Investment, Blue Owl Capital, and Enterprise Products Partners offer yields from 5.9% to over 13%, sustained by operational cash flows or long distribution histories. Market conditions shift: Lower index yields and possible Fed easing are steering investors toward dependable dividend payers.

### 相關股票

- [OBDC.US](https://longbridge.com/zh-HK/quote/OBDC.US.md)
- [EPD.US](https://longbridge.com/zh-HK/quote/EPD.US.md)
- [MKC.US](https://longbridge.com/zh-HK/quote/MKC.US.md)
- [AGNC.US](https://longbridge.com/zh-HK/quote/AGNC.US.md)
- [OWL.US](https://longbridge.com/zh-HK/quote/OWL.US.md)
- [MKC.V.US](https://longbridge.com/zh-HK/quote/MKC.V.US.md)
- [AGNCM.US](https://longbridge.com/zh-HK/quote/AGNCM.US.md)
- [AGNCO.US](https://longbridge.com/zh-HK/quote/AGNCO.US.md)
- [AGNCZ.US](https://longbridge.com/zh-HK/quote/AGNCZ.US.md)
- [AGNCP.US](https://longbridge.com/zh-HK/quote/AGNCP.US.md)
- [AGNCN.US](https://longbridge.com/zh-HK/quote/AGNCN.US.md)
- [AGNCL.US](https://longbridge.com/zh-HK/quote/AGNCL.US.md)
- [OBDE.US](https://longbridge.com/zh-HK/quote/OBDE.US.md)
- [OTF.US](https://longbridge.com/zh-HK/quote/OTF.US.md)

## 相關資訊與研究

- [鉅亨速報 - Factset 最新調查：AGNC 投資 (AGNC-US) EPS 預估上修至 1.5 元，預估目標價為 11.50 元](https://longbridge.com/zh-HK/news/283553741.md)
- [強勁企業盈利為股市抵禦收益率上升提供緩衝，Barclays 表示](https://longbridge.com/zh-HK/news/287092504.md)
- [華爾街看好健康保險板塊，分析師上調多家公司評級](https://longbridge.com/zh-HK/news/287081375.md)
- [鉅亨速報 - Factset 最新調查：Roivant Sciences LtdROIV-US 的目標價調升至 38 元，幅度約 8.57%](https://longbridge.com/zh-HK/news/287126179.md)
- [美銀證券：ServiceNow 將受益於 AI 浪潮，而非被取代](https://longbridge.com/zh-HK/news/286773572.md)